spironolactone has been researched along with lactulose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bossone, CM | 1 |
| Fischer, R; Müting, D; Ordnung, W | 1 |
| Carmassi, F; De Giorgi, A; De Negri, F; Giannarelli, C | 1 |
| De Silva, AP; de Silva, HJ; Gunathilaka, ML; Luke, NV; Niriella, MA; Piyarathna, CL; Siriwardena, RC | 1 |
1 review(s) available for spironolactone and lactulose
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for spironolactone and lactulose
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
The liver: a pharmacologic perspective.
Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins | 1977 |
[Portal hypertension from the internal medicine viewpoint].
Topics: Furosemide; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Spironolactone; Vasopressins | 1976 |
Decompensated porto-pulmonary hypertension in a cirrhotic patient with thrombosis of portocaval shunt.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diet, Sodium-Restricted; Diuretics; Drug Therapy, Combination; Dyspnea; Edema; Female; Fibrinolytic Agents; Gastrointestinal Agents; Heparin, Low-Molecular-Weight; Humans; Hypertension, Portal; Hypertension, Pulmonary; Lactulose; Liver Cirrhosis; Portal Pressure; Portasystemic Shunt, Surgical; Spironolactone; Treatment Outcome; Vasodilator Agents; Venous Thrombosis | 2007 |
Possible gasoline-induced chronic liver injury due to occupational malpractice in a motor mechanic: a case report.
Topics: Automobiles; Cholagogues and Choleretics; Directive Counseling; Diuretics; Furosemide; Gasoline; Gastrointestinal Agents; Hepatomegaly; Humans; Hydrocarbons; Lactulose; Liver Cirrhosis; Male; Malpractice; Occupational Diseases; Occupational Exposure; Spironolactone; Treatment Outcome; Ursodeoxycholic Acid; Young Adult | 2017 |